Discovery of Novel and Selective Schiff Base Inhibitors as a Key for Drug Synthesis, Molecular Docking, and Pharmacological Evaluation

Imran Khan(Hazara University), Magda H. Abdellattif(Taif University), Rafaqat Hussain(Balochistan University of Information Technology, Engineering and Management Sciences), Wajid Rehman(Hazara University), Liaqat Rasheed(King Fahd University of Petroleum and Minerals), Ashwag S. Alanazi(Princess Nourah bint Abdulrahman University), Mohamed Hefnawy(King Saud University), Fazal Rahim(Hazara University), Shoaib Khan(Abbottabad University of Science and Technology)
ACS Omega
July 3, 2024
10.1021/acsomega.4c04599
Cited by 5

Related Papers

Synthesis of Metal–Organic Framework-Based ZIF-8@ZIF-67 Nanocomposites for Antibiotic Decomposition and Antibacterial Activities
|ACS Omega|2023|134
RETRACTED: A critical review on metal-organic frameworks (MOFs) based nanomaterials for biomedical applications: Designing, recent trends, challenges, and prospects
|Heliyon|2024|84
Phytomelatonin: A key regulator of redox and phytohormones signaling against biotic/abiotic stresses
|Redox Biology|2023|69
Synthesis, in vitro thymidine phosphorylase inhibitory activity and molecular docking study of novel pyridine-derived bis-oxadiazole bearing bis-schiff base derivatives
|Arabian Journal of Chemistry|2023|65
Metal/Covalent Organic Framework Encapsulated Lead-Free Halide Perovskite Hybrid Nanocatalysts: Multifunctional Applications, Design, Recent Trends, Challenges, and Prospects
|ACS Omega|2024|62